Cargando…
In Reply to “Letter to the Editor: AnaConDa Device: Solution to Perform Cardiac Surgery Without Intravenous Anesthetic During the Coronavirus Disease 2019 Pandemic”
Autores principales: | Kermad, Azzeddine, Volk, Thomas, Meiser, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760001/ https://www.ncbi.nlm.nih.gov/pubmed/33451952 http://dx.doi.org/10.1053/j.jvca.2020.12.035 |
Ejemplares similares
-
AnaConDa Device: Solution to Perform Cardiac Surgery Without Intravenous Anesthetic During the Corona Virus Disease 2019 Pandemic
por: Labaste, François, et al.
Publicado: (2021) -
In vitro performance evaluation of AnaConDa(TM)-100 and AnaConDa(TM)-50 compared to a circle breathing system for control and consumption of volatile anaesthetics
por: Bellgardt, Martin, et al.
Publicado: (2020) -
AnaConDa™ and Mirus™ for intensive care sedation, 24 h desflurane versus isoflurane in one patient
por: Bomberg, Hagen, et al.
Publicado: (2016) -
Comparison of the use of AnaConDa® versus AnaConDa-S® during the post-operative period of cardiac surgery under standard conditions of practice
por: Marcos-Vidal, Jose Miguel, et al.
Publicado: (2019) -
Sevoflurane administration from extracorporeal membrane oxygenation via the AnaConDa device for a patient with COVID-19: A breakthrough solution for the shortage of intravenous anesthetics
por: Iwasaki, Yudai, et al.
Publicado: (2022)